The Syndromic Surveillance of ArbaeenMass Gathering 2018 Specific - - PowerPoint PPT Presentation

the syndromic surveillance of arbaeenmass gathering 2018
SMART_READER_LITE
LIVE PREVIEW

The Syndromic Surveillance of ArbaeenMass Gathering 2018 Specific - - PowerPoint PPT Presentation

The Syndromic Surveillance of ArbaeenMass Gathering 2018 Specific Objectives The objectives of the surveillance system Early detection and rapid Early detection Early detection Rapid response & Numeration of of the outbreaks to the


slide-1
SLIDE 1

The Syndromic Surveillance of ArbaeenMass Gathering 2018

slide-2
SLIDE 2

Contoso

Pharmaceuticals

Early detection & Numeration of syndromes Early detection

  • f the outbreaks

Rapid response to the detected

  • utbreaks both

in Iraq and Iran

The objectives of the surveillance system

Early detection and rapid response to important

  • utbreaks during Arbaeen

mass gathering

Specific Objectives

slide-3
SLIDE 3

Contoso

Pharmaceuticals

Selected syndromes

  • 1. Acute watery diarrhoea
  • 2. Acute bloody diarrhoea
  • 3. Food poisoning
  • 4. Influenza like infections
  • 5. Sever acute respiratory infections
  • 6. Fever and haemorrhage
  • 7. Jaundice
  • 8. Fever & neurologic symptoms
  • 9. Sudden death
slide-4
SLIDE 4

Contoso

Pharmaceuticals

Case Definition:

  • For each syndrome a case definition was proposed; in this

case the health officers were able to count the number of cases.

  • A meeting was held for training the health staff who were

involved for the surveillance system .

slide-5
SLIDE 5

Contoso

Pharmaceuticals

Data collection method

  • Sentinel site data collection method
  • Two different categories of locations:
  • 1. At the border posts
  • 3 health posts at the Iraqi borders
  • 2 heath posts at the Pakistan and Afghanistan borders
  • 2. In a number of red crescent clinics in Iraq
  • 2 in Karbala
  • 2 in Najaf
  • 1 in Kazemeyn
slide-6
SLIDE 6

Contoso

Pharmaceuticals

Data collection method

  • All patients were screened

for any of the 9 syndromes at the entry of the targeted clinics.

  • The necessary data were

recorded in a prepared form

slide-7
SLIDE 7

Contoso

Pharmaceuticals

Data collection tool

  • We used an application installed on mobile phone for data

collection:

  • Health officer recorded data on their smart phone
  • They sent the collected data once they had accessibility to internet
  • Data were analysed in the Iranian CDC & the feed back was

prepared on the next morning

slide-8
SLIDE 8

Contoso

Pharmaceuticals

Data collection tool

  • The target groups of the feed back were:
  • Authorities of the Iranian MOH
  • Surveillance groups inside Iraq
  • Medical universities across the country

For timeline intervention

slide-9
SLIDE 9

Contoso

Pharmaceuticals

Results of the syndromic surveillance

  • During a 13 day period a total of 2935 patients were enrolled

with at least one of the proposed syndromes (screened from 111572 attended patients to the 5 red crescent clinics in Iraq)

slide-10
SLIDE 10

Contoso

Pharmaceuticals

Results of the syndromic surveillance

Syndromes Female Male Total Acute bloody diarrhea 24 41 65 Acute watery diarrhea 498 1111 1609 Sever acute respiratory infection 69 128 197 Fever & hemorrhage 1 1 Fever & neurologic fever 3 3 Jaundice 1 1 Influenza like infection 187 283 470 Food poisoning 236 353 589 Total 1014 1921 2935

slide-11
SLIDE 11

Contoso

Pharmaceuticals

Results of the syndromic surveillance

50 100 150 200 250 19-Oct 20-Oct 21-Oct 22-Oct 23-Oct 24-Oct 25-Oct 26-Oct 27-Oct 28-Oct 29-Oct 30-Oct 31-Oct

Trend of reported syndromes

Bloody diarrhea Watery Diarrhea SARI ILI Food posining

slide-12
SLIDE 12

Contoso

Pharmaceuticals

Evidence based interventions

  • We detected a number of outbreaks

during the pilgrimage and surveillance period:

  • Inspection of “Mokebs” for food water supply

by environmental health experts who were settled in different places on the roads leading to Karbala (31 persons)

  • 3021 inspections during 20 days
slide-13
SLIDE 13

Contoso

Pharmaceuticals

Evidence based interventions

  • 3404 sampling from suspected foods
  • 4119 chlorine measurements
slide-14
SLIDE 14

Contoso

Pharmaceuticals

Evidence based interventions

  • Training the pilgrims for hand hygiene and

food safety (45430 persons)

  • Training the servants of “MOKEBS” for

environmental health (13026 servants)

slide-15
SLIDE 15

Contoso

Pharmaceuticals

Challenges

During Arbaeen

  • We used cholera rapid test for a

number of diarrheal patients during the pilgrimage

  • We had difficulty for confirmation of

positive tests

  • It is necessary to implement a

microbiologic lab in order to confirm these results.

Challenges

slide-16
SLIDE 16

Contoso

Pharmaceuticals

Thank You

eshrati.b@iums.ac.ir Babak Eshrati

Questions?